Pakistan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
2.3 (2.04 - 2.61)	2019	Modelled	IHME
2.31 (2.05 - 2.61)	2018	Modelled	IHME
2.34 (2.05 - 2.66)	2017	Modelled	IHME
2.48 (2.18 - 2.80)	2016	Modelled	IHME
2.61 (2.30 - 2.93)	2015	Modelled	IHME
2.58 (2.29 - 2.88)	2014	Modelled	IHME
2.52 (2.27 - 2.79)	2013	Modelled	IHME
2.45 (2.23 - 2.69)	2012	Modelled	IHME
2.38 (2.19 - 2.61)	2011	Modelled	IHME
2.36 (2.17 - 2.57)	2010	Modelled	IHME
2.37 (2.18 - 2.57)	2009	Modelled	IHME
2.39 (2.21 - 2.59)	2008	Modelled	IHME
2.42 (2.24 - 2.62)	2007	Modelled	IHME
2.46 (2.27 - 2.66)	2006	Modelled	IHME
2.5 (2.31 - 2.70)	2005	Modelled	IHME
2.55 (2.36 - 2.75)	2004	Modelled	IHME
2.61 (2.40 - 2.83)	2003	Modelled	IHME
2.68 (2.46 - 2.91)	2002	Modelled	IHME
2.75 (2.52 - 3.01)	2001	Modelled	IHME
2.84 (2.58 - 3.12)	2000	Modelled	IHME
2.95 (2.68 - 3.25)	1999	Modelled	IHME
3.08 (2.81 - 3.39)	1998	Modelled	IHME
3.22 (2.93 - 3.54)	1997	Modelled	IHME
3.35 (3.02 - 3.69)	1996	Modelled	IHME
3.44 (3.08 - 3.81)	1995	Modelled	IHME
3.51 (3.11 - 3.93)	1994	Modelled	IHME
3.57 (3.13 - 4.03)	1993	Modelled	IHME
3.63 (3.15 - 4.12)	1992	Modelled	IHME
3.67 (3.16 - 4.21)	1991	Modelled	IHME
3.7 (3.15 - 4.30)	1990	Modelled	IHME
5.63 (4.44 - 7.31)	2015	Modelled	WHO
2.1 (2 - 3.30)	2016	Modelled	Razavi-Shearer et al, 2018
2.76 (2.73 - 2.79)	2013	Modelled	Schweitzer et al, 2015
2.5	2010	Survey/reported	Qureshi et al, 2010

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.54 (0.43 - 0.68)	2019	Modelled	IHME
0.57 (0.45 - 0.71)	2018	Modelled	IHME
0.6 (0.48 - 0.75)	2017	Modelled	IHME
0.64 (0.51 - 0.79)	2016	Modelled	IHME
0.67 (0.54 - 0.83)	2015	Modelled	IHME
0.68 (0.55 - 0.83)	2014	Modelled	IHME
0.69 (0.56 - 0.83)	2013	Modelled	IHME
0.69 (0.57 - 0.83)	2012	Modelled	IHME
0.7 (0.57 - 0.83)	2011	Modelled	IHME
0.7 (0.58 - 0.83)	2010	Modelled	IHME
0.71 (0.58 - 0.84)	2009	Modelled	IHME
0.71 (0.59 - 0.84)	2008	Modelled	IHME
0.72 (0.60 - 0.85)	2007	Modelled	IHME
0.73 (0.60 - 0.86)	2006	Modelled	IHME
0.74 (0.62 - 0.87)	2005	Modelled	IHME
0.85 (0.71 - 1)	2004	Modelled	IHME
1.12 (0.92 - 1.31)	2003	Modelled	IHME
1.44 (1.18 - 1.69)	2002	Modelled	IHME
1.73 (1.42 - 2.04)	2001	Modelled	IHME
1.91 (1.57 - 2.27)	2000	Modelled	IHME
2.01 (1.64 - 2.39)	1999	Modelled	IHME
2.08 (1.71 - 2.50)	1998	Modelled	IHME
2.15 (1.77 - 2.58)	1997	Modelled	IHME
2.2 (1.80 - 2.66)	1996	Modelled	IHME
2.23 (1.81 - 2.72)	1995	Modelled	IHME
2.26 (1.82 - 2.77)	1994	Modelled	IHME
2.28 (1.81 - 2.82)	1993	Modelled	IHME
2.3 (1.82 - 2.86)	1992	Modelled	IHME
2.32 (1.82 - 2.90)	1991	Modelled	IHME
2.33 (1.81 - 2.96)	1990	Modelled	IHME
2.75 (2.02 - 3.67)	2015	Modelled	WHO

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
4,171,710 (3,558,800 - 4,846,440)	1990	Modelled	IHME
4,234,710 (3,646,690 - 4,859,340)	1991	Modelled	IHME
4,281,040 (3,718,690 - 4,861,930)	1992	Modelled	IHME
4,313,350 (3,776,650 - 4,860,730)	1993	Modelled	IHME
4,334,610 (3,835,120 - 4,855,760)	1994	Modelled	IHME
4,348,030 (3,889,370 - 4,815,740)	1995	Modelled	IHME
4,327,710 (3,904,830 - 4,766,560)	1996	Modelled	IHME
4,260,630 (3,867,260 - 4,684,680)	1997	Modelled	IHME
4,171,380 (3,801,100 - 4,585,960)	1998	Modelled	IHME
4,086,900 (3,715,540 - 4,501,230)	1999	Modelled	IHME
4,036,180 (3,663,590 - 4,439,350)	2000	Modelled	IHME
4,014,950 (3,672,820 - 4,394,270)	2001	Modelled	IHME
4,000,200 (3,675,710 - 4,358,230)	2002	Modelled	IHME
3,995,520 (3,687,300 - 4,339,680)	2003	Modelled	IHME
4,005,010 (3,706,720 - 4,333,430)	2004	Modelled	IHME
4,032,280 (3,732,890 - 4,355,180)	2005	Modelled	IHME
4,069,410 (3,764,670 - 4,400,700)	2006	Modelled	IHME
4,109,650 (3,798,770 - 4,451,620)	2007	Modelled	IHME
4,158,850 (3,842,360 - 4,512,170)	2008	Modelled	IHME
4,224,410 (3,892,410 - 4,593,480)	2009	Modelled	IHME
4,314,540 (3,965,620 - 4,695,770)	2010	Modelled	IHME
4,469,290 (4,104,000 - 4,889,530)	2011	Modelled	IHME
4,696,520 (4,274,710 - 5,163,820)	2012	Modelled	IHME
4,953,520 (4,453,840 - 5,484,720)	2013	Modelled	IHME
5,193,350 (4,605,970 - 5,793,680)	2014	Modelled	IHME
5,364,760 (4,728,230 - 6,034,320)	2015	Modelled	IHME
5,212,860 (4,582,100 - 5,887,100)	2016	Modelled	IHME
5,018,070 (4,396,320 - 5,713,410)	2017	Modelled	IHME
5,073,500 (4,497,760 - 5,730,560)	2018	Modelled	IHME
5,161,400 (4,570,900 - 5,838,200)	2019	Modelled	IHME
3,962,000 (3,906,000 - 6,364,000)	2016	Modelled	Razavi-Shearer et al, 2018

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
7.23 (5.30 - 9.67)	2019	Modelled	IHME
7.26 (5.25 - 9.75)	2018	Modelled	IHME
7.3 (5.27 - 9.76)	2017	Modelled	IHME
7.25 (5.28 - 9.58)	2016	Modelled	IHME
7.26 (5.25 - 9.54)	2015	Modelled	IHME
7.33 (5.45 - 9.62)	2014	Modelled	IHME
7.38 (5.43 - 9.64)	2013	Modelled	IHME
7.4 (5.50 - 9.68)	2012	Modelled	IHME
7.48 (5.35 - 9.72)	2011	Modelled	IHME
7.57 (5.54 - 9.79)	2010	Modelled	IHME
7.63 (5.58 - 9.82)	2009	Modelled	IHME
7.67 (5.75 - 9.81)	2008	Modelled	IHME
7.7 (5.73 - 9.85)	2007	Modelled	IHME
7.79 (5.83 - 9.85)	2006	Modelled	IHME
7.89 (6.04 - 9.93)	2005	Modelled	IHME
8 (6.05 - 10)	2004	Modelled	IHME
8.13 (6.11 - 10.20)	2003	Modelled	IHME
8.27 (6.17 - 10.40)	2002	Modelled	IHME
8.37 (6.22 - 10.60)	2001	Modelled	IHME
8.4 (6.13 - 10.80)	2000	Modelled	IHME
8.39 (6.17 - 10.70)	1999	Modelled	IHME
8.46 (6.19 - 10.80)	1998	Modelled	IHME
8.6 (6.19 - 11)	1997	Modelled	IHME
8.67 (6.06 - 11.20)	1996	Modelled	IHME
8.69 (6.06 - 11.50)	1995	Modelled	IHME
8.6 (5.87 - 11.60)	1994	Modelled	IHME
8.57 (5.64 - 11.60)	1993	Modelled	IHME
8.59 (5.59 - 11.80)	1992	Modelled	IHME
8.57 (5.48 - 12.10)	1991	Modelled	IHME
8.56 (5.41 - 12.20)	1990	Modelled	IHME

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
16,208 (11,878 - 21,656)	2019	Modelled	IHME
15,916 (11,508 - 21,399)	2018	Modelled	IHME
15,686 (11,324 - 20,956)	2017	Modelled	IHME
15,249 (11,104 - 20,149)	2016	Modelled	IHME
14,927 (10,797 - 19,620)	2015	Modelled	IHME
14,749 (10,970 - 19,338)	2014	Modelled	IHME
14,515 (10,671 - 18,946)	2013	Modelled	IHME
14,209 (10,556 - 18,591)	2012	Modelled	IHME
14,023 (10,034 - 18,218)	2011	Modelled	IHME
13,860 (10,135 - 17,916)	2010	Modelled	IHME
13,622 (9,966 - 17,526)	2009	Modelled	IHME
13,359 (10,008 - 17,093)	2008	Modelled	IHME
13,074 (9,734 - 16,719)	2007	Modelled	IHME
12,898 (9,656 - 16,298)	2006	Modelled	IHME
12,732 (9,747 - 16,025)	2005	Modelled	IHME
12,584 (9,524 - 15,756)	2004	Modelled	IHME
12,465 (9,378 - 15,639)	2003	Modelled	IHME
12,370 (9,232 - 15,624)	2002	Modelled	IHME
12,201 (9,063 - 15,388)	2001	Modelled	IHME
11,948 (8,715 - 15,402)	2000	Modelled	IHME
11,638 (8,562 - 14,813)	1999	Modelled	IHME
11,459 (8,383 - 14,627)	1998	Modelled	IHME
11,372 (8,182 - 14,594)	1997	Modelled	IHME
11,202 (7,830 - 14,491)	1996	Modelled	IHME
10,973 (7,655 - 14,565)	1995	Modelled	IHME
10,612 (7,238 - 14,262)	1994	Modelled	IHME
10,342 (6,811 - 14,010)	1993	Modelled	IHME
10,135 (6,599 - 13,963)	1992	Modelled	IHME
9,894 (6,329 - 13,986)	1991	Modelled	IHME
9,657 (6,100 - 13,729)	1990	Modelled	IHME
15,531	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
18 (15 - 21)	2019	Modelled	IHME
18 (15 - 21)	2018	Modelled	IHME
18 (14 - 21)	2017	Modelled	IHME
18 (15 - 21)	2016	Modelled	IHME
18 (15 - 21)	2015	Modelled	IHME
18 (15 - 21)	2014	Modelled	IHME
18 (15 - 21)	2013	Modelled	IHME
18 (15 - 21)	2012	Modelled	IHME
18 (15 - 21)	2011	Modelled	IHME
18 (15 - 21)	2010	Modelled	IHME
18 (15 - 21)	2009	Modelled	IHME
18 (15 - 21)	2008	Modelled	IHME
18 (15 - 21)	2007	Modelled	IHME
17 (15 - 21)	2006	Modelled	IHME
17 (15 - 21)	2005	Modelled	IHME
17 (15 - 21)	2004	Modelled	IHME
17 (14 - 21)	2003	Modelled	IHME
17 (14 - 20)	2002	Modelled	IHME
17 (14 - 21)	2001	Modelled	IHME
17 (14 - 20)	2000	Modelled	IHME
17 (14 - 20)	1999	Modelled	IHME
17 (14 - 20)	1998	Modelled	IHME
17 (14 - 20)	1997	Modelled	IHME
17 (14 - 20)	1996	Modelled	IHME
16 (14 - 20)	1995	Modelled	IHME
16 (13 - 19)	1994	Modelled	IHME
16 (13 - 19)	1993	Modelled	IHME
16 (13 - 19)	1992	Modelled	IHME
16 (13 - 19)	1991	Modelled	IHME
16 (13 - 19)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
75	2019	Survey/reported	WHO/UNICEF
77	2020	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
18 (16 - 21)	2015	Survey/reported	Larney et al, 2017

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
0	2015	Survey/reported	NACP, 2015.

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HBV testing policy

Pregnant women

Source:

HepB birth dose policy

Yes

Source:

Eligible for HBV generic medicines

Source: MPP

Year of birth dose introduction

2016

Source: WHO

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Some (11-30%)

Source: WHO

% of substance use disorder facilities offering hepatitis treatment

Few (1-10%)

Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
1.68 (1.34 - 2.09)	2019	Modelled	IHME
1.69 (1.34 - 2.09)	2018	Modelled	IHME
1.69 (1.35 - 2.09)	2017	Modelled	IHME
1.9 (1.53 - 2.36)	2016	Modelled	IHME
2.16 (1.75 - 2.68)	2015	Modelled	IHME
2.27 (1.83 - 2.82)	2014	Modelled	IHME
2.36 (1.91 - 2.92)	2013	Modelled	IHME
2.43 (1.96 - 3.01)	2012	Modelled	IHME
2.48 (2 - 3.07)	2011	Modelled	IHME
2.5 (2.01 - 3.09)	2010	Modelled	IHME
2.5 (2.01 - 3.09)	2009	Modelled	IHME
2.49 (2.01 - 3.07)	2008	Modelled	IHME
2.48 (2 - 3.06)	2007	Modelled	IHME
2.47 (1.99 - 3.04)	2006	Modelled	IHME
2.46 (1.98 - 3.02)	2005	Modelled	IHME
2.39 (1.93 - 2.96)	2004	Modelled	IHME
2.27 (1.84 - 2.80)	2003	Modelled	IHME
2.13 (1.72 - 2.62)	2002	Modelled	IHME
2.02 (1.63 - 2.49)	2001	Modelled	IHME
1.97 (1.59 - 2.44)	2000	Modelled	IHME
1.99 (1.60 - 2.45)	1999	Modelled	IHME
2.02 (1.62 - 2.48)	1998	Modelled	IHME
2.06 (1.65 - 2.53)	1997	Modelled	IHME
2.09 (1.68 - 2.58)	1996	Modelled	IHME
2.11 (1.68 - 2.60)	1995	Modelled	IHME
2.1 (1.69 - 2.59)	1994	Modelled	IHME
2.1 (1.68 - 2.59)	1993	Modelled	IHME
2.09 (1.67 - 2.59)	1992	Modelled	IHME
2.06 (1.65 - 2.58)	1991	Modelled	IHME
2.04 (1.63 - 2.55)	1990	Modelled	IHME
3.8 (2.80 - 3.90)	2015	Modelled	Blach et al, 2017
5.8 (1.40 - 8.70)	2014	Modelled	Gower et al, 2014

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
4.09 (3.06 - 4.27)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
6.7 (1.60 - 10)	2014	Modelled	Gower et al, 2014
4.8	2010	Survey/reported	Qureshi et al, 2010

Showing out of

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
36.5 (0 - 79.10)	2013	Modelled	Degenhardt L et al, 2017

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
2,296,440 (1,837,780 - 2,879,210)	1990	Modelled	IHME
2,382,570 (1,906,760 - 2,974,290)	1991	Modelled	IHME
2,460,490 (1,968,470 - 3,054,960)	1992	Modelled	IHME
2,531,480 (2,028,830 - 3,129,000)	1993	Modelled	IHME
2,597,020 (2,081,780 - 3,197,950)	1994	Modelled	IHME
2,658,730 (2,124,940 - 3,276,080)	1995	Modelled	IHME
2,702,280 (2,163,840 - 3,337,740)	1996	Modelled	IHME
2,722,000 (2,185,740 - 3,349,360)	1997	Modelled	IHME
2,733,700 (2,199,120 - 3,363,000)	1998	Modelled	IHME
2,754,760 (2,215,310 - 3,399,270)	1999	Modelled	IHME
2,803,840 (2,258,200 - 3,463,370)	2000	Modelled	IHME
2,944,570 (2,373,760 - 3,628,350)	2001	Modelled	IHME
3,191,680 (2,569,210 - 3,922,550)	2002	Modelled	IHME
3,487,540 (2,814,590 - 4,295,300)	2003	Modelled	IHME
3,768,300 (3,042,760 - 4,650,720)	2004	Modelled	IHME
3,962,380 (3,195,820 - 4,866,450)	2005	Modelled	IHME
4,087,980 (3,294,130 - 5,037,820)	2006	Modelled	IHME
4,213,500 (3,395,510 - 5,194,500)	2007	Modelled	IHME
4,336,800 (3,492,500 - 5,350,300)	2008	Modelled	IHME
4,456,480 (3,582,670 - 5,515,400)	2009	Modelled	IHME
4,571,090 (3,669,760 - 5,663,070)	2010	Modelled	IHME
4,652,200 (3,747,000 - 5,754,320)	2011	Modelled	IHME
4,675,290 (3,765,490 - 5,780,790)	2012	Modelled	IHME
4,645,390 (3,747,540 - 5,740,640)	2013	Modelled	IHME
4,568,540 (3,689,300 - 5,665,190)	2014	Modelled	IHME
4,451,800 (3,595,980 - 5,521,580)	2015	Modelled	IHME
3,992,790 (3,214,200 - 4,952,200)	2016	Modelled	IHME
3,626,650 (2,900,230 - 4,497,330)	2017	Modelled	IHME
3,697,200 (2,948,190 - 4,577,980)	2018	Modelled	IHME
3,774,440 (2,999,760 - 4,679,890)	2019	Modelled	IHME
7,172,000 (5,363,000 - 7,487,000)	2015	Modelled	Blach et al, 2017

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
2,219,000 (1,659,000 - 2,316,000)	2019	Modelled	Dugan et al., 2021

HCV-related death rate

National

Download

Value (Deaths per 100,000)	Year	Type	Source
7.87 (5.69 - 11)	2019	Modelled	IHME
8.03 (5.78 - 10.90)	2018	Modelled	IHME
8.15 (5.94 - 11)	2017	Modelled	IHME
8.13 (6 - 10.90)	2016	Modelled	IHME
8.16 (5.96 - 11)	2015	Modelled	IHME
8.24 (6.09 - 11.10)	2014	Modelled	IHME
8.27 (5.99 - 11.10)	2013	Modelled	IHME
8.25 (6.07 - 11)	2012	Modelled	IHME
8.31 (6.19 - 10.90)	2011	Modelled	IHME
8.4 (6.24 - 11)	2010	Modelled	IHME
8.47 (6.35 - 11.10)	2009	Modelled	IHME
8.53 (6.63 - 11.20)	2008	Modelled	IHME
8.59 (6.60 - 11.10)	2007	Modelled	IHME
8.7 (6.68 - 11.10)	2006	Modelled	IHME
8.82 (6.81 - 11.30)	2005	Modelled	IHME
8.96 (7 - 11.60)	2004	Modelled	IHME
9.11 (7.08 - 11.60)	2003	Modelled	IHME
9.27 (7.18 - 12)	2002	Modelled	IHME
9.38 (7.23 - 12.10)	2001	Modelled	IHME
9.45 (7.22 - 12.40)	2000	Modelled	IHME
9.48 (7.18 - 12.50)	1999	Modelled	IHME
9.6 (7.17 - 12.90)	1998	Modelled	IHME
9.78 (7.28 - 13.10)	1997	Modelled	IHME
9.89 (7.14 - 13.50)	1996	Modelled	IHME
9.96 (7.09 - 13.90)	1995	Modelled	IHME
9.91 (6.88 - 14.10)	1994	Modelled	IHME
9.92 (6.73 - 14.40)	1993	Modelled	IHME
9.99 (6.61 - 14.70)	1992	Modelled	IHME
10 (6.50 - 14.90)	1991	Modelled	IHME
10.1 (6.43 - 15.20)	1990	Modelled	IHME

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
17,644 (12,752 - 24,554)	2019	Modelled	IHME
17,606 (12,684 - 23,927)	2018	Modelled	IHME
17,502 (12,769 - 23,584)	2017	Modelled	IHME
17,094 (12,617 - 22,890)	2016	Modelled	IHME
16,793 (12,256 - 22,683)	2015	Modelled	IHME
16,569 (12,252 - 22,347)	2014	Modelled	IHME
16,252 (11,766 - 21,883)	2013	Modelled	IHME
15,845 (11,655 - 21,185)	2012	Modelled	IHME
15,579 (11,600 - 20,467)	2011	Modelled	IHME
15,371 (11,414 - 20,171)	2010	Modelled	IHME
15,122 (11,335 - 19,790)	2009	Modelled	IHME
14,862 (11,539 - 19,580)	2008	Modelled	IHME
14,579 (11,208 - 18,799)	2007	Modelled	IHME
14,395 (11,063 - 18,452)	2006	Modelled	IHME
14,232 (10,984 - 18,192)	2005	Modelled	IHME
14,098 (11,009 - 18,265)	2004	Modelled	IHME
13,975 (10,856 - 17,735)	2003	Modelled	IHME
13,861 (10,739 - 17,926)	2002	Modelled	IHME
13,671 (10,545 - 17,661)	2001	Modelled	IHME
13,440 (10,269 - 17,568)	2000	Modelled	IHME
13,148 (9,955 - 17,386)	1999	Modelled	IHME
12,993 (9,708 - 17,473)	1998	Modelled	IHME
12,925 (9,625 - 17,267)	1997	Modelled	IHME
12,775 (9,227 - 17,400)	1996	Modelled	IHME
12,572 (8,953 - 17,585)	1995	Modelled	IHME
12,227 (8,487 - 17,376)	1994	Modelled	IHME
11,973 (8,126 - 17,396)	1993	Modelled	IHME
11,786 (7,806 - 17,382)	1992	Modelled	IHME
11,566 (7,503 - 17,243)	1991	Modelled	IHME
11,379 (7,256 - 17,165)	1990	Modelled	IHME
12,122	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
50 (44 - 54)	2019	Modelled	IHME
50 (45 - 55)	2018	Modelled	IHME
50 (44 - 54)	2017	Modelled	IHME
49 (44 - 54)	2016	Modelled	IHME
49 (44 - 54)	2015	Modelled	IHME
49 (44 - 54)	2014	Modelled	IHME
49 (44 - 54)	2013	Modelled	IHME
50 (44 - 54)	2012	Modelled	IHME
50 (45 - 54)	2011	Modelled	IHME
50 (45 - 54)	2010	Modelled	IHME
50 (45 - 54)	2009	Modelled	IHME
50 (45 - 54)	2008	Modelled	IHME
50 (45 - 55)	2007	Modelled	IHME
50 (45 - 55)	2006	Modelled	IHME
50 (45 - 55)	2005	Modelled	IHME
50 (45 - 55)	2004	Modelled	IHME
51 (45 - 55)	2003	Modelled	IHME
51 (46 - 56)	2002	Modelled	IHME
51 (46 - 56)	2001	Modelled	IHME
51 (46 - 56)	2000	Modelled	IHME
51 (46 - 56)	1999	Modelled	IHME
52 (46 - 56)	1998	Modelled	IHME
52 (47 - 57)	1997	Modelled	IHME
52 (47 - 57)	1996	Modelled	IHME
52 (47 - 57)	1995	Modelled	IHME
52 (47 - 57)	1994	Modelled	IHME
52 (47 - 57)	1993	Modelled	IHME
53 (47 - 57)	1992	Modelled	IHME
53 (47 - 58)	1991	Modelled	IHME
53 (47 - 58)	1990	Modelled	IHME

Showing out of

Technical notes

Number of persons treated for HCV

National

Download

Value	Year	Type	Source
6,500	2015	Survey/reported	WHO, 2018
161,000	2016	Survey/reported	WHO, 2018

Showing out of

Technical notes

Cumulative number of persons treated for HCV

National

Download

Value	Year	Type	Source
200,000	2018	Survey/reported	WHO, 2021

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
18 (16 - 21)	2015	Survey/reported	Larney et al, 2017

Technical notes

Number of 28-pill count bottles exported from Indian manufacturers (SOF-based regimens)

National

Download

Value	Year	Type	Source
73,386	2016	Survey/reported	CHAI HCV Market Report
100,002	2017	Survey/reported	CHAI HCV Market Report
104,504	2018	Survey/reported	CHAI HCV Market Report
68,661	2019	Survey/reported	CHAI HCV Market Report

Showing out of

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
0	2015	Survey/reported	NACP, 2015.

Price of HCV cure (Lowest average FOB price for 3 months of pangenotypic regimens)

National

Download

Value (US $)	Year	Type	Source
231	2016	Survey/reported	CHAI HCV Market Report
84	2017	Survey/reported	CHAI HCV Market Report
60	2018	Survey/reported	CHAI HCV Market Report
75	2019	Survey/reported	CHAI HCV Market Report